{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:08:36Z","timestamp":1783908516984,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00210-026-05319-4","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:53:52Z","timestamp":1776135232000},"page":"14267-14297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ligustrazine attenuates high-fat diet\u2013induced neurobehavioral deficits and hepatic dysfunction via modulation of the HO-1\/Nrf-2\/SIRT-1\/PPAR-\u03b1 axis"],"prefix":"10.1007","volume":"399","author":[{"given":"Aarti","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6133-1399","authenticated-orcid":false,"given":"Pradeep Kumar","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"5319_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020174","author":"JC Arroyave-Ospina","year":"2021","unstructured":"Arroyave-Ospina JC et al (2021) Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10020174","journal-title":"Antioxidants"},{"issue":"5","key":"5319_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pctr.0020021","volume":"2","author":"H Attallah","year":"2007","unstructured":"Attallah H et al (2007) Effects of growth hormone and Pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial. PLoS Clin Trials 2(5):e21. https:\/\/doi.org\/10.1371\/journal.pctr.0020021","journal-title":"PLoS Clin Trials"},{"issue":"3","key":"5319_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/diacare.29.03.06.dc05-2004","volume":"29","author":"A Basu","year":"2006","unstructured":"Basu A et al (2006) Effects of Pioglitazone versus Glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes. Diabetes Care 29(3):510\u2013514. https:\/\/doi.org\/10.2337\/diacare.29.03.06.dc05-2004","journal-title":"Diabetes Care"},{"key":"5319_CR4","doi-asserted-by":"publisher","unstructured":"Bhattacharya I\u00a0et al (2024) \u2018Investigation of the potential connections between NAFLD-associated Alzheimer\u2019s disease: bioinformatics analysis of shared genes\u2019.\u00a0Environ Model Softw [Preprint].\u00a0https:\/\/doi.org\/10.21203\/rs.3.rs-4667019\/v1","DOI":"10.21203\/rs.3.rs-4667019\/v1"},{"key":"5319_CR5","doi-asserted-by":"publisher","DOI":"10.2174\/1570180819666220405232333","author":"SNA Bukhari","year":"2022","unstructured":"Bukhari SNA, Yogesh R (2022) An overview of tetramethylpyrazine (Ligustrazine) and its derivatives as potent anti-Alzheimer\u2019s disease agents. Lett Drug Des Discov. https:\/\/doi.org\/10.2174\/1570180819666220405232333","journal-title":"Lett Drug Des Discov"},{"issue":"10","key":"5319_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ph14101057","volume":"14","author":"A Cano","year":"2021","unstructured":"Cano A et al (2021) Epilepsy in neurodegenerative diseases: related drugs and molecular pathways. Pharmaceuticals 14(10):1057. https:\/\/doi.org\/10.3390\/ph14101057","journal-title":"Pharmaceuticals"},{"key":"5319_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.02.025","author":"Z Chen","year":"2020","unstructured":"Chen Z et al (2020) Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.025","journal-title":"Free Radic Biol Med"},{"key":"5319_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2004.06.021","author":"H Cortez-Pinto","year":"2004","unstructured":"Cortez-Pinto H, Camilo ME (2004) Non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis (NAFLD\/NASH): diagnosis and clinical course. Best Pract Res Clin Gastroenterol. https:\/\/doi.org\/10.1016\/j.bpg.2004.06.021","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"5319_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.redox.2013.08.003","volume":"1","author":"Y Cui","year":"2013","unstructured":"Cui Y et al (2013) Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation. Redox Biol 1(1):433\u2013440. https:\/\/doi.org\/10.1016\/j.redox.2013.08.003","journal-title":"Redox Biol"},{"key":"5319_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282633","author":"M Cushman","year":"2023","unstructured":"Cushman M et al (2023) Nonalcoholic fatty liver disease and cognitive impairment: a prospective cohort study. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0282633","journal-title":"PLoS One"},{"key":"5319_CR11","doi-asserted-by":"publisher","unstructured":"Dallakyan S, Olson AJ (2015) \u2018Small-molecule library screening by docking with PyRx\u2019. In:\u00a0Journal of Human Values. pp 243\u2013250. https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19","DOI":"10.1007\/978-1-4939-2269-7_19"},{"issue":"11","key":"5319_CR12","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/ejn.15992","volume":"57","author":"A Elgellaie","year":"2023","unstructured":"Elgellaie A et al (2023) Pro\u2010inflammatory cytokines IL\u20101\u03b1, IL\u20106 and TNF\u2010\u03b1 in major depressive disorder: sex\u2010specific associations with psychological symptoms. Eur J Neurosci 57(11):1913\u20131928. https:\/\/doi.org\/10.1111\/ejn.15992","journal-title":"Eur J Neurosci"},{"issue":"1","key":"5319_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ca.23792","volume":"35","author":"NS Erekat","year":"2022","unstructured":"Erekat NS (2022) Apoptosis and its therapeutic implications in neurodegenerative diseases. Clin Anat 35(1):65\u201378. https:\/\/doi.org\/10.1002\/ca.23792","journal-title":"Clin Anat"},{"issue":"2","key":"5319_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/hmg\/ddv477","volume":"25","author":"MA Esmaeili","year":"2016","unstructured":"Esmaeili MA et al (2016) Preferential PPAR-\u03b1 activation reduces neuroinflammation, and blocks neurodegeneration in vivo. Hum Mol Genet 25(2):317\u2013327. https:\/\/doi.org\/10.1093\/hmg\/ddv477","journal-title":"Hum Mol Genet"},{"key":"5319_CR15","doi-asserted-by":"publisher","unstructured":"Firneisz G (2014) \u2018Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?\u2019.\u00a0World J Gastroenterol\u00a0[Preprint].\u00a0https:\/\/doi.org\/10.3748\/wjg.v20.i27.9072","DOI":"10.3748\/wjg.v20.i27.9072"},{"key":"5319_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708959","author":"TCM Fontes-Cal","year":"2021","unstructured":"Fontes-Cal TCM et al (2021) Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.708959","journal-title":"Front Immunol"},{"key":"5319_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. https:\/\/doi.org\/10.1093\/clinchem\/18.6.499","journal-title":"Clin Chem"},{"issue":"6","key":"5319_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063337","volume":"25","author":"M Giuffr\u00e8","year":"2024","unstructured":"Giuffr\u00e8 M et al (2024) The metabolic impact of nonalcoholic fatty liver disease on cognitive dysfunction: a comprehensive clinical and pathophysiological review. Int J Mol Sci 25(6):3337. https:\/\/doi.org\/10.3390\/ijms25063337","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5319_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1463-1326.2008.00965.x","volume":"11","author":"AK Gupta","year":"2009","unstructured":"Gupta AK et al (2009) Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome. Diabetes Obes Metab 11(4):330\u2013337. https:\/\/doi.org\/10.1111\/j.1463-1326.2008.00965.x","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"5319_CR20","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.3390\/cimb45060321","volume":"45","author":"J Han","year":"2023","unstructured":"Han J et al (2023) SIRT1 activator E1231 alleviates nonalcoholic fatty liver disease by regulating lipid metabolism. Curr Issues Mol Biol 45(6):5052\u20135070. https:\/\/doi.org\/10.3390\/cimb45060321","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"5319_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0155-1","volume":"8","author":"J Horder","year":"2018","unstructured":"Horder J et al (2018) Glutamate and GABA in autism spectrum disorder\u2014a translational magnetic resonance spectroscopy study in man and rodent models. Transl Psychiatry 8(1):106. https:\/\/doi.org\/10.1038\/s41398-018-0155-1","journal-title":"Transl Psychiatry"},{"key":"5319_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.632843","author":"X Huang","year":"2021","unstructured":"Huang X et al (2021) Tetramethylpyrazine improves cognitive impairment and modifies the hippocampal proteome in two mouse models of Alzheimer\u2019s disease. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.632843","journal-title":"Front Cell Dev Biol"},{"key":"5319_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093066","author":"Y Ji","year":"2020","unstructured":"Ji Y et al (2020) The molecular and mechanistic insights based on gut\u2013liver axis: nutritional target for non-alcoholic fatty liver disease (NAFLD) improvement. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21093066","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5319_CR24","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.62347\/YXRQ5742","volume":"16","author":"H Jin","year":"2024","unstructured":"Jin H (2024) Ligustrazine alleviates spinal cord injury-induced neuropathic pain by inhibiting the TLR4\/NF-\u03baB signaling pathway. Am J Transl Res 16(8):3557\u20133571. https:\/\/doi.org\/10.62347\/YXRQ5742","journal-title":"Am J Transl Res"},{"issue":"5","key":"5319_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/apt.15395","volume":"50","author":"D Kim","year":"2019","unstructured":"Kim D et al (2019) Depression is associated with non\u2010alcoholic fatty liver disease among adults in the United States. Aliment Pharmacol Ther 50(5):590\u2013598. https:\/\/doi.org\/10.1111\/apt.15395","journal-title":"Aliment Pharmacol Ther"},{"key":"5319_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.physbeh.2016.02.007","volume":"157","author":"S Krishna","year":"2016","unstructured":"Krishna S et al (2016) Time-dependent behavioral, neurochemical, and metabolic dysregulation in female C57BL\/6 mice caused by chronic high-fat diet intake. Physiol Behav 157:196\u2013208. https:\/\/doi.org\/10.1016\/j.physbeh.2016.02.007","journal-title":"Physiol Behav"},{"key":"5319_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/08927022.2023.2256624","author":"S Kumar","year":"2023","unstructured":"Kumar S et al (2023) In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer. Mol Simul. https:\/\/doi.org\/10.1080\/08927022.2023.2256624","journal-title":"Mol Simul"},{"key":"5319_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10817-9","author":"S Kumar","year":"2024","unstructured":"Kumar S et al (2024) In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-024-10817-9","journal-title":"Mol Divers"},{"key":"5319_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149251","volume":"1846","author":"M kumar","year":"2025","unstructured":"kumar M et al (2025) Therapeutic efficacy of Genistein in activation of neuronal AC\/cAMP\/CREB\/PKA and mitochondrial ETC-Complex pathways in experimental model of autism: evidence from CSF, blood plasma and brain analysis. Brain Res 1846:149251. https:\/\/doi.org\/10.1016\/j.brainres.2024.149251","journal-title":"Brain Res"},{"issue":"3","key":"5319_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ejphar.2011.07.030","volume":"668","author":"M Kusunoki","year":"2011","unstructured":"Kusunoki M et al (2011) Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886. Eur J Pharmacol 668(3):486\u2013491. https:\/\/doi.org\/10.1016\/j.ejphar.2011.07.030","journal-title":"Eur J Pharmacol"},{"key":"5319_CR31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M211450200","author":"L Lad","year":"2003","unstructured":"Lad L et al (2003) Comparison of the heme-free and -bound crystal structures of human heme oxygenase-1. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M211450200","journal-title":"J Biol Chem"},{"issue":"6","key":"5319_CR32","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.2337\/db12-0428","volume":"62","author":"J Lamontagne","year":"2013","unstructured":"Lamontagne J et al (2013) Pioglitazone acutely reduces energy metabolism and insulin secretion in rats. Diabetes 62(6):2122\u20132129. https:\/\/doi.org\/10.2337\/db12-0428","journal-title":"Diabetes"},{"key":"5319_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/792726","author":"JS Li","year":"2012","unstructured":"Li JS et al (2012) Ligustrazine injection for chronic pulmonary heart disease: a systematic review and meta-analysis. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2012\/792726","journal-title":"Evid Based Complement Alternat Med"},{"key":"5319_CR34","doi-asserted-by":"publisher","unstructured":"Li G et al (2020) \u2018Ligustrazine ameliorates lipopolysaccharide-induced neurocognitive impairment by activating autophagy via the PI3K\/AKT\/mTOR pathway\u2019.\u00a0Int J Mol Med\u00a0[Preprint].\u00a0\u00a0https:\/\/doi.org\/10.3892\/ijmm.2020.4548","DOI":"10.3892\/ijmm.2020.4548"},{"issue":"2","key":"5319_CR35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.intimp.2015.09.020","volume":"29","author":"C Lu","year":"2015","unstructured":"Lu C et al (2015) Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress. Int Immunopharmacol 29(2):613\u2013621. https:\/\/doi.org\/10.1016\/j.intimp.2015.09.020","journal-title":"Int Immunopharmacol"},{"key":"5319_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11010091","author":"Y Ma","year":"2022","unstructured":"Ma Y et al (2022) \u2018Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease\u2019, Antioxidants [Preprint]. Available at: https:\/\/doi.org\/10.3390\/antiox11010091","journal-title":"Available at:"},{"key":"5319_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03026-6","author":"SA Mahmoud","year":"2024","unstructured":"Mahmoud SA et al (2024) Enhanced upregulation of SIRT1 via pioglitazone and ligustrazine confers protection against ethanol-induced gastric ulcer in rats. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03026-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"10","key":"5319_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/qjmed\/hcg120","volume":"96","author":"SDH Malnick","year":"2003","unstructured":"Malnick SDH, Beergabel M, Knobler H (2003) Non-alcoholic fatty liver: a common manifestation of a metabolic disorder. QJM 96(10):699\u2013709. https:\/\/doi.org\/10.1093\/qjmed\/hcg120","journal-title":"QJM"},{"key":"5319_CR39","doi-asserted-by":"publisher","unstructured":"Medina-Julio D\u00a0et al (2024) \u2018From Liver to Brain: how MAFLD\/MASLD Impacts Cognitive Function\u2019. Med Sci Mon [Preprint]. https:\/\/doi.org\/10.12659\/MSM.943417","DOI":"10.12659\/MSM.943417"},{"issue":"6","key":"5319_CR40","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.270316","volume":"15","author":"S Mehan","year":"2020","unstructured":"Mehan S et al (2020) Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats. Neural Regen Res 15(6):1140. https:\/\/doi.org\/10.4103\/1673-5374.270316","journal-title":"Neural Regen Res"},{"key":"5319_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3628","author":"MJ Millan","year":"2012","unstructured":"Millan MJ et al (2012) Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov. https:\/\/doi.org\/10.1038\/nrd3628","journal-title":"Nat Rev Drug Discov"},{"key":"5319_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2019.04.007","author":"R Moretti","year":"2019","unstructured":"Moretti R, Caruso P, Gazzin S (2019) Non-alcoholic fatty liver disease and neurological defects. Ann Hepatol. https:\/\/doi.org\/10.1016\/j.aohep.2019.04.007","journal-title":"Ann Hepatol"},{"issue":"16","key":"5319_CR43","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"5319_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.115280","volume":"476","author":"P Sethi","year":"2025","unstructured":"Sethi P et al (2025) The SIRT-1\/Nrf2\/HO-1 axis: guardians of neuronal health in neurological disorders. Behav Brain Res 476:115280. https:\/\/doi.org\/10.1016\/j.bbr.2024.115280","journal-title":"Behav Brain Res"},{"key":"5319_CR45","doi-asserted-by":"publisher","unstructured":"Shang Y, Widman L, Hagstr\u00f6m H (2022) \u2018Nonalcoholic fatty liver disease and risk of dementia\u2019.\u00a0Neurology\u00a099(6). https:\/\/doi.org\/10.1212\/WNL.0000000000200853","DOI":"10.1212\/WNL.0000000000200853"},{"key":"5319_CR46","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429326799241121104310","author":"K Sherawat","year":"2024","unstructured":"Sherawat K et al (2024) Neuroprotective potential of Tanshinone-IIA in mitigating propionic acidinduced experimental autism-like behavioral and neurochemical alterations: insights into c-JNK and p38MAPK pathways. Curr Mol Pharmacol. https:\/\/doi.org\/10.2174\/0118761429326799241121104310","journal-title":"Curr Mol Pharmacol"},{"key":"5319_CR47","doi-asserted-by":"publisher","unstructured":"Sierra ML\u00a0et al\u00a0(2007) \u2018Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPAR\u03b1 agonists. 1. Discovery of a novel series of potent HDLc raising agents\u2019.\u00a0J Med Chem [Preprint]. https:\/\/doi.org\/10.1021\/jm058056x","DOI":"10.1021\/jm058056x"},{"issue":"1","key":"5319_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.metabol.2004.07.008","volume":"54","author":"SR Smith","year":"2005","unstructured":"Smith SR et al (2005) Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial. Metabolism 54(1):24\u201332. https:\/\/doi.org\/10.1016\/j.metabol.2004.07.008","journal-title":"Metabolism"},{"key":"5319_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01713-8","author":"\u00d3 Soto-Angona","year":"2020","unstructured":"Soto-Angona \u00d3 et al (2020) Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches. BMC Med. https:\/\/doi.org\/10.1186\/s12916-020-01713-8","journal-title":"BMC Med"},{"issue":"000","key":"5319_CR50","doi-asserted-by":"publisher","first-page":"000","DOI":"10.14218\/JCTH.2024.00481","volume":"000","author":"M Sun","year":"2025","unstructured":"Sun M et al (2025) Investigation of HO-1 regulation of liver fibrosis related to nonalcoholic fatty liver disease through the SIRT1\/TGF-\u00df\/Smad3 pathway. J Clin Transl Hepatol 000(000):000\u2013000. https:\/\/doi.org\/10.14218\/JCTH.2024.00481","journal-title":"J Clin Transl Hepatol"},{"key":"5319_CR51","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-4354","author":"F Tacke","year":"2021","unstructured":"Tacke F, Weiskirchen R (2021) Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention. Ann Transl Med. https:\/\/doi.org\/10.21037\/atm-20-4354","journal-title":"Ann Transl Med"},{"key":"5319_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320622","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H (2020) Nafld and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2020-320622","journal-title":"Gut"},{"key":"5319_CR53","doi-asserted-by":"publisher","unstructured":"Tiwari A et al (2021) \u2018Neuroprotective effect of \u03b1-mangostin in the ameliorating propionic acid-induced experimental model of autism in wistar rats\u2019.\u00a0Brain Sci [Preprint].\u00a0https:\/\/doi.org\/10.3390\/brainsci11030288","DOI":"10.3390\/brainsci11030288"},{"key":"5319_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70255","author":"A Tiwari","year":"2025","unstructured":"Tiwari A, Shukla A, Kumar Samal P (2025) Evaluation of anti-hyperlipidemic and anti-atherogenic activity of asiatic acid and its effect on lipid peroxidation in hyperlipidemic rats. J Biochem Mol Toxicol. https:\/\/doi.org\/10.1002\/jbt.70255","journal-title":"J Biochem Mol Toxicol"},{"issue":"5","key":"5319_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biology11050792","volume":"11","author":"S Todisco","year":"2022","unstructured":"Todisco S et al (2022) PPAR alpha as a metabolic modulator of the liver: role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Biology 11(5):792. https:\/\/doi.org\/10.3390\/biology11050792","journal-title":"Biology"},{"key":"5319_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/105828","author":"G Verdile","year":"2015","unstructured":"Verdile G et al (2015) Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer\u2019s disease. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2015\/105828","journal-title":"Mediators Inflamm"},{"key":"5319_CR57","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17094","volume":"12","author":"M Wang","year":"2024","unstructured":"Wang M et al (2024a) The role of sirtuin1 in liver injury: molecular mechanisms and novel therapeutic target. PeerJ 12:e17094. https:\/\/doi.org\/10.7717\/peerj.17094","journal-title":"PeerJ"},{"key":"5319_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1373663","author":"Z Wang","year":"2024","unstructured":"Wang Z et al (2024) The protective effects of ligustrazine on ischemic stroke: a systematic review and meta-analysis of preclinical evidence and possible mechanisms. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1373663","journal-title":"Front Pharmacol"},{"key":"5319_CR59","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.678136","author":"AF Winkel","year":"2015","unstructured":"Winkel AF et al (2015) Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M115.678136","journal-title":"J Biol Chem"},{"key":"5319_CR60","doi-asserted-by":"publisher","DOI":"10.1021\/jm301431y","author":"X Zhao","year":"2013","unstructured":"Zhao X et al (2013) The 2.5 \u00c5 crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD + ) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition. J Med Chem. https:\/\/doi.org\/10.1021\/jm301431y","journal-title":"J Med Chem"},{"key":"5319_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.01.097","author":"J Zou","year":"2018","unstructured":"Zou J et al (2018) Recent progress in the structural modification and pharmacological activities of ligustrazine derivatives. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.097","journal-title":"Eur J Med Chem"},{"key":"5319_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2023.109330","author":"Q Zuo","year":"2024","unstructured":"Zuo Q et al (2024) Navigating nonalcoholic fatty liver disease (NAFLD): exploring the roles of estrogens, pharmacological and medical interventions, and life style. Steroids. https:\/\/doi.org\/10.1016\/j.steroids.2023.109330","journal-title":"Steroids"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05319-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05319-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05319-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:44:28Z","timestamp":1783907068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05319-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5319"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05319-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for these experiments was obtained from the Institutional Animal Ethics Committee (IAEC) of the Department of Pharmacy at Guru Ghasidas Vishwavidyalaya (GGV), Bilaspur, India, under reference number 112\/IAEC\/Pharmacy\/2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical guideline"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}